31601-68-0 Usage
Uses
Used in Pharmaceutical Industry:
4-(2,5-DIOXO-PYRROLIDIN-1-YL)-BUTYRIC ACID is used as a prodrug of glutamine for the treatment of various bodily disorders such as cancer, intestinal inflammation, and immune system dysfunctions. Its anti-inflammatory and immunomodulatory properties contribute to its potential therapeutic use in these conditions.
Used in Cancer Treatment:
4-(2,5-DIOXO-PYRROLIDIN-1-YL)-BUTYRIC ACID is used as a potential therapeutic agent for cancer treatment. It may help in modulating the immune response and reducing inflammation associated with cancer, thereby improving the effectiveness of cancer therapies.
Used in Intestinal Inflammation Treatment:
4-(2,5-DIOXO-PYRROLIDIN-1-YL)-BUTYRIC ACID is used as an anti-inflammatory agent for the treatment of intestinal inflammation. Its ability to modulate the immune response and reduce inflammation can help alleviate symptoms and promote healing in individuals with inflammatory bowel diseases.
Used in Immune System Dysfunction Treatment:
4-(2,5-DIOXO-PYRROLIDIN-1-YL)-BUTYRIC ACID is used as an immunomodulatory agent for the treatment of immune system dysfunctions. Its potential to regulate immune responses can help restore balance in the immune system and improve overall health.
Used in Cognitive Function and Mental Health Improvement:
4-(2,5-DIOXO-PYRROLIDIN-1-YL)-BUTYRIC ACID is used as a potential cognitive enhancer and mental health supporter due to its role in the synthesis of neurotransmitters in the brain. Its ability to influence neurotransmitter production may contribute to improved cognitive function and mental well-being.
Check Digit Verification of cas no
The CAS Registry Mumber 31601-68-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,0 and 1 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 31601-68:
(7*3)+(6*1)+(5*6)+(4*0)+(3*1)+(2*6)+(1*8)=80
80 % 10 = 0
So 31601-68-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H11NO4/c10-6-3-4-7(11)9(6)5-1-2-8(12)13/h1-5H2,(H,12,13)
31601-68-0Relevant academic research and scientific papers
Amide compounds for regulating WNT signal channel and application of compounds
-
Paragraph 0139; 0141, (2019/07/11)
The invention belongs to the technical field of medicine, and particularly relates to amide compounds for regulating a WNT signal channel and an application of the compounds. The compounds have a structure represented by a general formula I shown in the description.
Solid phase-solid state synthesis of N-alkyl imides from anhydrides
Chandrasekhar,Padmaja,Raza
, p. 1597 - 1599 (2007/10/03)
Preparation of N-alkyl imides from anhydrides is developed on polymer support in solid state assisted by microwave for the first time.
Ruthenium Tetroxide Oxidation of 1-Azabicycloalkan-2-ones
Yoshifuji, Shigeyuki,Arakawa, Yukimi,Nitta, Yoshihiro
, p. 5042 - 5047 (2007/10/02)
The ruthenium tetroxide (RuO4) oxidation of 1-azabicycloalkan-2-ones was investigated.The oxidation of quinolizidin-4-one (4), indolizidin-3-one (9), pyrrolizidin-3-one (11) and tetrahydro-1H,3H-pyrrolooxazol-3-one (12) occured at the bridgehead tertiary carbon atom and afforded the corresponding hydroxy compounds (from 11 and 12) or the imidobutyric acid derivatives (from 4 and 9).This regioselectivity is contrary to the general situation in the oxidation of N-acyl cyclic amines.Howewer, 1-azabicyclooctan-8-one (17) was oxidized at the secondary carbon atom to give the 2,8-dione (18).Keywords: oxidation; ruthenium tetroxide oxidation; hydroxylation; regioselectivity; 1-azabicycloalkan-2-one; ruthenium tetroxide; two-phase method
